drugset / Trial / NCT00277914
Flibanserin Randomized Withdrawal Trial in Pre-menopausal Women
NaSingle-groupOpen-labelTreatment
Summary
To estimate the duration of efficacy with continued treatment of double-blind flibanserin or placebo over twenty-four weeks of treatment.
Timeline
- Start
- 2006-01
- Primary completion
- 2007-07
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | flibanserin | Small molecule | — | — |